0001209191-23-016456.txt : 20230306
0001209191-23-016456.hdr.sgml : 20230306
20230306181435
ACCESSION NUMBER: 0001209191-23-016456
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230302
FILED AS OF DATE: 20230306
DATE AS OF CHANGE: 20230306
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Murdock Hunter R.
CENTRAL INDEX KEY: 0001934008
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37635
FILM NUMBER: 23710319
MAIL ADDRESS:
STREET 1: 22 CORTLAND STREET, 16TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10007
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Axsome Therapeutics, Inc.
CENTRAL INDEX KEY: 0001579428
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 454241907
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 22 CORTLANDT STREET, 16TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10007
BUSINESS PHONE: (212) 332-3241
MAIL ADDRESS:
STREET 1: 22 CORTLANDT STREET, 16TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10007
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-03-02
0
0001579428
Axsome Therapeutics, Inc.
AXSM
0001934008
Murdock Hunter R.
C/O AXSOME THERAPEUTICS, INC.
22 CORTLANDT ST, 16TH FLOOR
NEW YORK
NY
10007
0
1
0
0
General Counsel
Employee Stock Option (Right to Buy)
65.32
2023-03-02
4
A
0
29773
0.00
A
2033-03-01
Common Stock
29773
29773
D
Restricted Stock Units
2023-03-02
4
A
0
16883
0.00
A
Common Stock
16883
16883
D
The option will vest in substantially equal quarterly installments over four years such that the option will be fully vested on March 2, 2027.
Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.
25% of the RSUs will vest on the one (1) year anniversary of the date of grant. The remaining RSUs will vest in in three substantially equal annual installments, such that the RSUs will be fully vested on March 2, 2027. Vested shares will be delivered to the reporting person upon the earlier of (i) the closing of a Change in Control (as defined in the Issuer's Amended and Restated 2015 Omnibus Incentive Compensation Plan (the "Plan"), (ii) the reporting person's separation of service from the Issuer (including termination with or without Cause (as defined in the Plan), or termination due to death or disability), or (iii) seven (7) years from the date of grant.
/s/ Hunter Murdock
2023-03-06